Can my GP prescribe medical cannabis in the UK?

Medical cannabis is no longer just a symbol of counterculture rebellion. Today in the UK, it’s a legitimate — if tightly controlled — treatment option for certain conditions. But if you’re wondering, “Can my GP prescribe medical cannabis?”, the answer comes with several important caveats shaped by a decade of policy shifts, public interest, and cautious clinical practice.

A tale of transformation: From counterculture to clinic

For decades, cannabis was thought of mainly as an illicit drug associated with underground movements or recreational use. This image profoundly shaped UK legislation and attitudes for years.

What changed? The pivot came in October 2018, when the UK government reclassified cannabis-based products for medicinal use (CBPMs) as Schedule 2 controlled drugs, enabling prescribers to legally recommend cannabis-derived medicines in certain situations.

This was a watershed moment, sparking widespread public and patient interest—but also setting clear boundaries about who can prescribe and how the medicines should be used.

2018 legal rescheduling: The cautious opening of doors

The rescheduling meant that, from 2018 onwards, cannabis medicines like Sativex (for multiple sclerosis spasticity) and Epidyolex (for rare epilepsy syndromes) could be prescribed on the NHS. Private prescriptions followed too, albeit at high personal cost.

But here’s the catch: the UK government and NHS took a measured approach. Unlike some countries which allow broad prescribing by general practitioners (GPs), UK medical cannabis prescribing remains restricted to specialists — consultants working in hospitals or clinics with relevant expertise.

This specialist-only prescribing rule exists largely because:

    Evidence for many uses of cannabis medicines is still emerging Safety, dosing, and long-term effects warrant careful oversight It allows the NHS to maintain tight controls and standard protocols

Why can’t GPs just prescribe medical cannabis? The current rules

Despite the rise in public awareness and patient advocacy, your GP can usually not prescribe medical cannabis in the UK. This is due to strict guidelines from regulatory bodies like the National Institute for Health and Care Excellence (NICE) and the Medicines and Healthcare products Regulatory Agency (MHRA).

GPs may be open to discussing cannabis medicines with patients — and some patients do ask:

“If cannabis works, why can’t my GP prescribe it for my chronic pain?"

However, GPs are expected to refer patients who might benefit from medical cannabis to a specialist consultant who can formally initiate treatment. This ensures that a patient’s diagnosis, previous treatments, and suitability for cannabis-based medicine are thoroughly evaluated.

How does specialist-only prescribing affect patients?

For many patients, the specialist referral requirement presents challenges:

image

Long wait times: Getting an appointment with a qualified consultant can take months. Geographic barriers: Some regions have limited specialists familiar with medical cannabis. High costs in private care: Private prescriptions come out of pocket and can be expensive.

Yet this approach helps minimise potential misuse, improper dosing, or prescribing cannabis where evidence is insufficient.

image

Patient research and question-led consultations

The surge in public curiosity and patient-led research on medical cannabis is a sign of the times. People with chronic conditions or complex symptoms often arrive at GP appointments armed with detailed online information and specific questions:

    “Is medical cannabis a treatment option for my condition?” “How can I get a referral to a specialist?” “What are the risks vs benefits?”

It’s important for patients to ask effectively. A good question might be:

“Given my ongoing symptoms and treatments so far, could you refer me to a pain specialist who can assess if cannabis-based medicine might help?”

This is more effective than asking a GP to prescribe directly, given the current UK legal framework.

Summary: Where GPs fit in the medical cannabis landscape

Role What they can do Limitations General Practitioners (GPs)
    Discuss cannabis as a treatment option Provide information and advice Refer patients to specialists
    Cannot initiate medical cannabis prescriptions Not authorised to monitor cannabis dosing or effects
Specialist Consultants
    Assess suitability for medical cannabis Prescribe cannabis medicines where evidence supports use Monitor patient outcomes and adjust treatment
    Generally limited to certain approved conditions Prescribing remains cautious and highly controlled

Looking ahead: Will UK prescribing restrictions change?

Calls continue for broader access to medical cannabis in the UK. Patient groups and some clinicians argue that more GPs should be empowered to prescribe, especially for chronic pain and other common conditions.

However, regulators remain cautious. Robust research, long-term safety data, and better training for prescribers are prerequisites to any expansion.

For now, understanding the specialist-only prescribing model and navigating referral pathways remains key for patients wondering “how to ask GP about cannabis”.

Additional tips when discussing medical cannabis with your GP

    Bring a summary of your medical history and treatments tried so far Be clear about your symptoms and impact on daily life Ask about local specialists who have experience with medical cannabis Understand that your GP’s role is to support your care pathway, not to prescribe directly

Akismet anti-spam notice

This blog welcomes patient cannabis rescheduled 2018 UK questions and contributions, but to maintain quality discussions, all comments are monitored using the Akismet anti-spam tool.

Share this article

    Share on WhatsApp Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn